Literature DB >> 15814590

RhoA-Rho kinase pathway mediates thrombin- and U-46619-induced phosphorylation of a myosin phosphatase inhibitor, CPI-17, in vascular smooth muscle cells.

Huan Pang1, Zhenheng Guo, Wen Su, Zhongwen Xie, Masumi Eto, Ming C Gong.   

Abstract

Protein kinase C-potentiated phosphatase inhibitor of 17 kDa (CPI-17) mediates some agonist-induced smooth muscle contraction by suppressing the myosin phosphatase in a phosphorylation-dependent manner. The physiologically relevant kinases that phosphorylate CPI-17 remain to be identified. Several previous studies have shown that some agonist-induced CPI-17 phosphorylation in smooth muscle tissues was attenuated by the Rho kinase (ROCK) inhibitor Y-27632, suggesting that ROCK is involved in agonist-induced CPI-17 phosphorylation. However, Y-27632 has recently been found to inhibit protein kinase C (PKC)-delta, a well-recognized CPI-17 kinase. Thus the role of ROCK in agonist-induced CPI-17 phosphorylation remains uncertain. The present study was designed to address this important issue. We selectively activated the RhoA pathway using inducible adenovirus-mediated expression of a constitutively active mutant RhoA (V14RhoA) in primary cultured rabbit aortic vascular smooth muscle cells (VSMCs). V14RhoA caused expression level-dependent CPI-17 phosphorylation at Thr38 as well as myosin phosphatase phosphorylation at Thr853. Importantly, we have shown that V14RhoA-induced CPI-17 phosphorylation was not affected by the PKC inhibitor GF109203X but was abolished by Y-27632, suggesting that ROCK but not PKC was involved. Furthermore, we have shown that the contractile agonists thrombin and U-46619 induced CPI-17 phosphorylation in VSMCs. Similarly to V14RhoA-induced CPI-17 phosphorylation, thrombin-induced CPI-17 phosphorylation was not affected by inhibition of PKC with GF109203X, but it was blocked by inhibition of RhoA with adenovirus-mediated expression of exoenzyme C3 as well as by Y-27632. Taken together, our present data provide the first clear evidence indicating that ROCK is responsible for thrombin- and U-46619-induced CPI-17 phosphorylation in primary cultured VSMCs.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15814590     DOI: 10.1152/ajpcell.00111.2005

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  27 in total

1.  Salt causes aging-associated hypertension via vascular Wnt5a under Klotho deficiency.

Authors:  Wakako Kawarazaki; Risuke Mizuno; Mitsuhiro Nishimoto; Nobuhiro Ayuzawa; Daigoro Hirohama; Kohei Ueda; Fumiko Kawakami-Mori; Shigeyoshi Oba; Takeshi Marumo; Toshiro Fujita
Journal:  J Clin Invest       Date:  2020-08-03       Impact factor: 14.808

2.  Phosphorylation-induced conformational switching of CPI-17 produces a potent myosin phosphatase inhibitor.

Authors:  Masumi Eto; Toshio Kitazawa; Fumiko Matsuzawa; Sei-Ichi Aikawa; Jason A Kirkbride; Noriyoshi Isozumi; Yumi Nishimura; David L Brautigan; Shin-Ya Ohki
Journal:  Structure       Date:  2007-12       Impact factor: 5.006

3.  Role of protein kinase Czeta and calcium entry in KCl-induced vascular smooth muscle calcium sensitization and feedback control of cellular calcium levels.

Authors:  Paul H Ratz; Amy S Miner
Journal:  J Pharmacol Exp Ther       Date:  2008-11-14       Impact factor: 4.030

4.  Relaxin regulates myofibroblast contractility and protects against lung fibrosis.

Authors:  Xiangwei Huang; Ying Gai; Naiheng Yang; Baogen Lu; Chrishan S Samuel; Victor J Thannickal; Yong Zhou
Journal:  Am J Pathol       Date:  2011-10-06       Impact factor: 4.307

5.  Effects of gomisin A on vascular contraction in rat aortic rings.

Authors:  Young Mi Seok; Young Whan Choi; Gyung-Duck Kim; Hye Young Kim; Yoh Takuwa; In Kyeom Kim
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-10-31       Impact factor: 3.000

6.  Smooth-muscle BMAL1 participates in blood pressure circadian rhythm regulation.

Authors:  Zhongwen Xie; Wen Su; Shu Liu; Guogang Zhao; Karyn Esser; Elizabeth A Schroder; Mellani Lefta; Harald M Stauss; Zhenheng Guo; Ming Cui Gong
Journal:  J Clin Invest       Date:  2014-12-08       Impact factor: 14.808

7.  17beta-estradiol attenuates vascular contraction through inhibition of RhoA/Rho kinase pathway.

Authors:  Enyue Yang; Su Bun Jeon; Inji Baek; Zheng-Ai Chen; Zheng Jin; In Kyeom Kim
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-03-19       Impact factor: 3.000

8.  Putative protein partners for the human CPI-17 protein revealed by bacterial two-hybrid screening.

Authors:  Kyung-mi Kim; Djanybek M Adyshev; Anita Kása; Evgeny A Zemskov; Irina A Kolosova; Csilla Csortos; Alexander D Verin
Journal:  Microvasc Res       Date:  2013-04-12       Impact factor: 3.514

9.  Role of calcium-independent phospholipase A2beta in high glucose-induced activation of RhoA, Rho kinase, and CPI-17 in cultured vascular smooth muscle cells and vascular smooth muscle hypercontractility in diabetic animals.

Authors:  Zhongwen Xie; Ming C Gong; Wen Su; Dongping Xie; John Turk; Zhenheng Guo
Journal:  J Biol Chem       Date:  2010-01-19       Impact factor: 5.157

10.  Flavone Attenuates Vascular Contractions by Inhibiting RhoA/Rho Kinase Pathway.

Authors:  Inji Baek; Su Bun Jeon; Min-Ji Song; Enyue Yang; Uy Dong Sohn; In Kyeom Kim
Journal:  Korean J Physiol Pharmacol       Date:  2009-06-30       Impact factor: 2.016

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.